TY - JOUR
T1 - Ventricular arrhythmia ablation lesions detectability and temporal changes on cardiac magnetic resonance
AU - Vunnam, Rama
AU - Maheshwari, Varun
AU - Jeudy, Jean
AU - Ghzally, Yousra
AU - Imanli, Hasan
AU - Abdulghani, Mohammed
AU - Mahat, Jagat B.
AU - Timilsina, Saroj
AU - Restrepo, Alejandro
AU - See, Vincent
AU - Shorofsky, Stephen
AU - Dickfeld, Timm
N1 - Publisher Copyright:
© 2020 Wiley Periodicals, Inc.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Background: Cardiac magnetic resonance (CMR) characteristics of ventricular radiofrequency ablation (RFA) lesions have only been incompletely defined. Aim: To determine the detectability and imaging characteristics of ventricular RFA lesions in an unselected patient cohort undergoing ventricular arrhythmia ablation. Methods and results: A retrospective chart review (n = 249) identified 36 patients with either pre-/postablation CMR (n = 14) or only postablation CMR (n = 22). Ablation lesions could be identified in 50% (n = 18) of patients. Nonvisualized lesions had more preexisting transmural late gadolinium enhancement (LGE) >75% at the ablation sites (21% vs 0.0%, P =.042), more prevalent ICD artifact (50% vs 0%, P =.001), and lower ejection fraction (35.8 ± 14.2% vs 45.3 ± 13.4%, P =.048). Early CMR imaging demonstrated a central “black” signal void (microvascular obstruction [MVO], n = 12, 67%) up to 32 days post-RFA, whereas late imaging showed a homogenously “white” gadolinium enhancement pattern (n = 6, 33%). MVO was only observed in nonfibrotic myocardium without preexisting LGE (n = 12) but was not observed in the scar with preexisting LGE (n = 3, P =.002) suggesting different wash-in/wash-out kinetics in scar/nonscar myocardium. Signal intensity (1909 vs 2534, P =.009) and contrast-to-noise ratio (−7.8 vs 16.3, P =.009) were significantly different between MVO and LGE lesions, respectively. Conclusion: Ventricular ablation lesions visualization is negatively affected by preexisting transmural scar, ICD artifact, and low ejection fraction. The transition of “black” MVO appearance to “white” LGE appearance on CMR occurs around 1 month following ablation, suggesting a change in histological characteristics of ablation lesions. This may affect the utility of CMR in the evaluation of the ventricular lesions, when undergoing real-time or repeat VT ablations.
AB - Background: Cardiac magnetic resonance (CMR) characteristics of ventricular radiofrequency ablation (RFA) lesions have only been incompletely defined. Aim: To determine the detectability and imaging characteristics of ventricular RFA lesions in an unselected patient cohort undergoing ventricular arrhythmia ablation. Methods and results: A retrospective chart review (n = 249) identified 36 patients with either pre-/postablation CMR (n = 14) or only postablation CMR (n = 22). Ablation lesions could be identified in 50% (n = 18) of patients. Nonvisualized lesions had more preexisting transmural late gadolinium enhancement (LGE) >75% at the ablation sites (21% vs 0.0%, P =.042), more prevalent ICD artifact (50% vs 0%, P =.001), and lower ejection fraction (35.8 ± 14.2% vs 45.3 ± 13.4%, P =.048). Early CMR imaging demonstrated a central “black” signal void (microvascular obstruction [MVO], n = 12, 67%) up to 32 days post-RFA, whereas late imaging showed a homogenously “white” gadolinium enhancement pattern (n = 6, 33%). MVO was only observed in nonfibrotic myocardium without preexisting LGE (n = 12) but was not observed in the scar with preexisting LGE (n = 3, P =.002) suggesting different wash-in/wash-out kinetics in scar/nonscar myocardium. Signal intensity (1909 vs 2534, P =.009) and contrast-to-noise ratio (−7.8 vs 16.3, P =.009) were significantly different between MVO and LGE lesions, respectively. Conclusion: Ventricular ablation lesions visualization is negatively affected by preexisting transmural scar, ICD artifact, and low ejection fraction. The transition of “black” MVO appearance to “white” LGE appearance on CMR occurs around 1 month following ablation, suggesting a change in histological characteristics of ablation lesions. This may affect the utility of CMR in the evaluation of the ventricular lesions, when undergoing real-time or repeat VT ablations.
UR - http://www.scopus.com/inward/record.url?scp=85081554227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081554227&partnerID=8YFLogxK
U2 - 10.1111/pace.13886
DO - 10.1111/pace.13886
M3 - Article
C2 - 32052461
AN - SCOPUS:85081554227
SN - 0147-8389
VL - 43
SP - 314
EP - 321
JO - PACE - Pacing and Clinical Electrophysiology
JF - PACE - Pacing and Clinical Electrophysiology
IS - 3
ER -